Announced
Synopsis
Mindray, a company that develops, manufactures, and markets medical devices, agreed to acquire HyTest, a manufacturer of scientifically created antibodies, from Summa Equity, a thematic investment companyб for $665m. "With the resources available from Mindray, we can further develop our capabilities to serve our customers and fulfill their needs for best-in-class reagents for developing reliable and sensitive immunoassays on various platforms," Juhana Rauramo, HyTest CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.